1,807
Views
7
CrossRef citations to date
0
Altmetric
Articles

Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis

ORCID Icon, , &
Pages 1052-1059 | Received 12 Mar 2021, Accepted 18 Jun 2021, Published online: 12 Jul 2021

References

  • Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462.
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
  • European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the LEASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
  • Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
  • Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.
  • Ucar F, Sezer S, Ginis Z, et al. APRI, the FIB-4 score, and Forn’s index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol. 2013;25:1076–1081.
  • Wang Q, Blank S, Fiel MI, et al. The severity of liver fibrosis influences the prognostic value of inflammation-based scores in hepatitis B-associated hepatocellular carcinoma. Ann Surg Oncol. 2015;22( 3):S1125–S1132.
  • Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61(1):292–302.
  • Singh S, Fujii LL, Murad MH, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(12):1573–1584. e1571–1572; quiz e1588–1579
  • Huang Z, Huang J, Zhou T, et al. Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: a meta-analysis. PLoS One. 2018;13(1):e0190512.
  • Kim R, Jeong WK, Kang TW, et al. Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension. Acta Radiol. 2019;60(12):1609–1618.
  • Lee DH, Lee JM, Yoon JH, et al. Liver stiffness measured by two-dimensional shear-wave elastography: prognostic value after radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2018;7(1):65–75.
  • Lee PC, Chiou YY, Chiu NC, et al. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Sci Rep. 2020;10(1):2006.
  • Lee SH, Kim SU, Jang JW, et al. Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma. Onco Targets Ther. 2015;8:347–356.
  • Lee YR, Park SY, Kim SU, et al. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol. 2017;32(5):1079–1086.
  • Rekik S, Allaire M, Mumana A, et al. Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis. J Gastroenterol Hepatol. 2020;35(1):142–150.
  • Xie X, Yu Y. Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablation. Transl Cancer Res Tcr. 2020;9(4):2518–2526.
  • Yoon JS, Lee YR, Kweon YO, et al. Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation. Eur J Gastroenterol Hepatol. 2018;30(10):1230–1236.
  • Jansen C, Moller P, Meyer C, et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67(4):1472–1484.
  • Piecha F, Mandorfer M, Peccerella T, et al. Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome. Am J Physiol Gastrointest Liver Physiol. 2018;315(4):G484–G494.
  • You MW, Kim KW, Shim JJ, et al. Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: a systematic review and time-to-event meta-analysis. J Gastroenterol Hepatol. 2020;36:601–608. https://doi.org/10.1111/jgh.15243
  • Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38(10):977–981.
  • Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 2006;59(3):432–441.
  • Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000;231(4):544–551.
  • Berzigotti A, Reig M, Abraldes JG, et al. Value of transient elastography measured with fibroscan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2015;261(4):e105.
  • Jung KS, Kim SU, Choi GH, et al. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan(R)). Ann Surg Oncol. 2012;19(13):4278–4286.
  • Jeong WK, Lim HK, Lee HK, et al. Principles and clinical application of ultrasound elastography for diffuse liver disease. Ultrasonography. 2014;33(3):149–160.